Diabetes Care Devices Market by Type, Patient Care Settings, and Country - BRIC Forecast to 2025 - ResearchAndMarkets.com

DUBLIN--()--The "Diabetes Care Devices Market by Type (SMBG, CGMS, Lancets, Insulin Pumps, Insulin Pens, Insulin Syringes, Mobile Apps), Patient Care Settings (Hospitals & Specialty Clinics, Self & Home Care), and Country (Brazil, Russia, India, China) - Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

The diabetes care devices (BRIC) market size is projected to reach USD 4.3 billion by 2025 from USD 1.7 billion in 2020, at a CAGR of 16.2% during the forecast period.

The growth in this market is primarily attributed to the sharp increase in diabetes, increasing awareness of diabetes management due to the rising number of diabetes awareness campaigns and screening camps, favorable national health strategies, and government-led endorsement of medical devices.

By type, under the insulin delivery devices segment, insulin pens to hold the largest share during the forecast period

Within the type category, the diabetes care devices (BRIC) market has been segmented into blood glucose monitoring systems, insulin delivery devices, and diabetes management mobile applications. Within the insulin delivery devices segment, insulin pens held the largest share in the market. The increasing affordability of insulin pens, convenience, ease-of-use, and technological advancements in these devices that promote integrated diabetes management support the growth of this segment.

By end-user, the self/ home healthcare segment is expected to grow at a higher rate during the forecast period (2020-2025)

Based on end-user, the diabetes care devices (BRIC) market has been segmented into hospital & specialty clinics and self/home healthcare. The self/home healthcare segment is expected to grow at a higher CAGR due to the increasing awareness of self-management of diabetes, increasing portability of diabetes care devices, and technological innovations that provide real-time insights for patients and healthcare providers for decision-making regarding diabetes control and treatment planning.

India is projected to grow at the highest CAGR

China is expected to account for the largest share of the diabetes care devices (BRIC) market in 2019. The large share of this region can primarily be attributed to the sharp increase in the diabetic population in the past decade and endorsements of medical devices by the government. On the other hand, India is expected to witness the highest CAGR during the forecast period due to the increasing government investment in the medical devices industry, high prevalence of type 1 and gestational diabetes cases, and increasing diabetes awareness creation through campaigns and screening camps.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Industry Insights

6 Diabetes Care Devices Market, by Type

7 Diabetes Care Devices Market, by Patient Care Settings

7.1 Introduction

7.2 Self/Home Healthcare

7.3 Hospitals & Diabetes Specialty Clinics

8 Diabetes Care Devices Market in BRIC Countries

8.1 Introduction

8.2 China: Diabetes Care Devices Market

8.2.1 Introduction

8.2.2 Market Drivers

8.2.2.1 Sharp Increase in Diabetes in the Past Decade

8.2.2.2 Favorable National Health Strategies

8.2.2.3 Government-Led Endorsement of the Medical Device Industry

8.2.3 Market Restraints

8.2.3.1 Traditional Chinese Medicine As an Alternative

8.2.3.2 High Cost of Advanced Diabetes Management Devices

8.2.4 Market Opportunities

8.2.4.1 Significant Advancements and Leveraging of Artificial Intelligence and Big Data

8.2.5 Market Challenges

8.2.5.1 Lack of Adherence of Patients to Recommended Diabetes Treatment Guidelines

8.3 India: Diabetes Care Devices Market

8.3.1 Introduction

8.3.2 Market Drivers

8.3.2.1 High Prevalence of Diabetes

8.3.2.2 Government's Make in India Campaign to Encourage Local Manufacturing of Medical Devices

8.3.2.3 Diabetes Awareness Campaigns and Screening Camps

8.3.3 Market Restraints

8.3.3.1 Lack of Accessibility to Healthcare

8.3.3.2 Inadequate Health Insurance Coverage

8.3.4 Market Opportunities

8.3.4.1 Rising Adoption of Mhealth

8.3.5 Market Challenges

8.3.5.1 Shortage of Healthcare Professionals in Diabetes Management

8.4 Brazil: Diabetes Care Devices Market

8.4.1 Introduction

8.4.2 Market Drivers

8.4.2.1 High Prevalence of Diabetes

8.4.2.2 Favorable Government Policies

8.4.3 Market Restraints

8.4.3.1 Lack of Awareness of Diabetes Care

8.4.3.2 High Prices of Advanced Diabetes Care Devices

8.4.4 Market Opportunities

8.4.4.1 Increasing Penetration of Smartphones and Rising Focus on Digital Health to Drive the Growth of Diabetes Management Platforms and Diabetes Management Mobile Applications

8.4.5 Market Challenges

8.4.5.1 Strict Regulatory Guidelines and Regulatory Process for Medical Devices

8.5 Russia: Diabetes Care Devices Market

8.5.1 Introduction

8.5.2 Market Drivers

8.5.2.1 Rising Elderly Population

8.5.2.2 Increasing Rate of Obesity

8.5.3 Market Restraints

8.5.3.1 Large Number of Undiagnosed Diabetics

8.5.4 Market Opportunities

8.5.4.1 Government Spending on Healthcare

8.5.4.2 Rising Investment of Pharma Market Players to Establish Local Manufacturing Plants

8.5.5 Market Challenges

8.5.5.1 Low Adoption of Glucose Monitoring Systems

9 Competitive Landscape

9.1 Overview

9.2 Product Benchmarking

9.3 Geographic Reach of the Top Market Players (2019)

9.4 R&D Expenditure: Key Players in the Diabetes Care Devices (Bric) Market

9.5 Market Share Analysis

10 Company Profiles

10.1 F. Hoffman-La Roche Ltd.

10.2 Abbott

10.3 Ascensia Diabetes Care Holdings Ag

10.4 Dexcom, Inc.

10.5 Medtronic Plc

10.6 B. Braun Melsungen Ag

10.7 Becton, Dickinson and Company

10.8 Acon Laboratories, Inc.

10.9 Arkray, Inc.

10.10 Sanofi

10.11 Novo Nordisk A/S

10.12 Terumo Corporation

10.13 Ypsomed

10.14 Sinocare, Inc.

10.15 Agamatrix Holdings Llc

10.16 Lifescan

10.17 Sd Biosensor, Inc.

10.18 Microgene Diagnostic Systems Pvt. Ltd.

10.19 Dr. Morepen

10.20 Bionime Corporation

10.21 Rossmax International Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/rqbdp4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900